Ultrafiltration Versus IV Diuretics in Worsening Heart Failure

NARecruitingINTERVENTIONAL
Enrollment

372

Participants

Timeline

Start Date

June 28, 2022

Primary Completion Date

September 30, 2026

Study Completion Date

December 31, 2026

Conditions
Heart Failure (for Example, Fluid Overload)Heart FailureFluid Overload
Interventions
DEVICE

Aquadex Smartflow® System

ultrafiltration

DRUG

IV Loop Diuretics

diuretics

Trial Locations (17)

10025

RECRUITING

Mount Sinai Morningside, New York

10029

RECRUITING

The Mount Sinai Hospital, New York

10075

RECRUITING

Northwell Health, New York

19001

RECRUITING

Abington Jefferson Health, Abington

23507

RECRUITING

Sentara Norfolk General Heart Hospital, Norfolk

33614

WITHDRAWN

St. Joseph's Hospital, Tampa

33756

COMPLETED

BayCare Medical Group, Morton Plant, Clearwater

38301

RECRUITING

Jackson Madison County General Hospital, Jackson

40536

RECRUITING

University of Kentucky, Lexington

43215

RECRUITING

The Ohio State University, Columbus

45219

RECRUITING

The Christ Hospital, Cincinnati

48202

RECRUITING

Henry Ford Health, Detroit

75207

RECRUITING

Baylor Scott & White Research Institute, Dallas

85721

RECRUITING

Banner Health, Tucson

90806

RECRUITING

MemorialCare, Long Beach Medical Center, Long Beach

92123

RECRUITING

Sharp Memorial Hospital, San Diego Cardiac Center, San Diego

94143

WITHDRAWN

University of California San Francisco, San Francisco

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nuwellis, Inc.

INDUSTRY

NCT05318105 - Ultrafiltration Versus IV Diuretics in Worsening Heart Failure | Biotech Hunter | Biotech Hunter